# Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation

> **NCT01873352** · PHASE3 · COMPLETED · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 302 (actual)

## Conditions studied

- Atrial Fibrillation
- Hypertension

## Interventions

- **PROCEDURE:** catheter ablation
- **PROCEDURE:** renal sympathetic denervation

## Key facts

- **NCT ID:** NCT01873352
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-20
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01873352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01873352, "Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01873352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*